NetworkNewsBreaks – Lexaria Bioscience Corp. (CS
Post# of 721
(Total Views: 273)
Posted On: 04/23/2018 4:10:52 PM
NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Initiates Human Clinical Study on TurboCBD Capsules; Presenting Breakthrough Nicotine Absorption Study Results
Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced that it has commenced a clinical study in Europe that is evaluating the cardiovascular and cognitive health effects of Lexaria’s high absorption TurboCBD™ capsules. The data produced by the study will be of significant benefit to the company and its partners, providing objective human performance findings that will support the development of Lexaria’s next-generation cannabinoid product formulations. Results of the study are anticipated within 90 days. In addition, Lexaria also announced that it will be presenting the results of its recent breakthrough nicotine absorption study at the Next Generation Nicotine Delivery 2018 USA conference taking place April 24-25 in Atlanta.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced that it has commenced a clinical study in Europe that is evaluating the cardiovascular and cognitive health effects of Lexaria’s high absorption TurboCBD™ capsules. The data produced by the study will be of significant benefit to the company and its partners, providing objective human performance findings that will support the development of Lexaria’s next-generation cannabinoid product formulations. Results of the study are anticipated within 90 days. In addition, Lexaria also announced that it will be presenting the results of its recent breakthrough nicotine absorption study at the Next Generation Nicotine Delivery 2018 USA conference taking place April 24-25 in Atlanta.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Lexaria Bioscience Corp. (LXRPD) Stock Research Links
Scroll down for more posts ▼